Quick Answer
SANGAMO THERAPEUTICS, INC reported Shares Outstanding of 350.69 million shares for fiscal year 2025.
SANGAMO THERAPEUTICS, INC Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 350.69M | +64.8% |
| 2024 | 212.84M | +19.5% |
| 2023 | 178.13M | +6.8% |
| 2022 | 166.79M | +14.3% |
| 2021 | 145.92M | +2.7% |
| 2020 | 142.06M | +22.5% |
| 2019 | 115.97M | +13.5% |
| 2018 | 102.19M | +19.4% |
| 2017 | 85.60M | +20.8% |
| 2016 | 70.87M | +0.7% |
| 2015 | 70.35M | +1.9% |
| 2014 | 69.06M | +11.0% |
| 2013 | 62.24M | +17.3% |
| 2012 | 53.06M | +1.0% |
| 2011 | 52.55M | +15.8% |
| 2010 | 45.38M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | 101.84M | +21.1% | +0.2% |
| June 30, 2018 | 101.62M | +21.7% | +16.8% |
| March 31, 2018 | 87.04M | +21.3% | +1.7% |
| December 31, 2017 | 85.60M | +20.8% | +1.8% |
| September 30, 2017 | 84.10M | +19.1% | +0.7% |
| June 30, 2017 | 83.48M | +18.2% | +16.3% |
| March 31, 2017 | 71.75M | +1.9% | +1.2% |
| December 31, 2016 | 70.87M | +0.7% | +0.4% |
- SANGAMO THERAPEUTICS, INC showed an increase of +64.8% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, SANGAMO THERAPEUTICS, INC’s shares outstanding has grown by 672.8% (from 45.38 million shares to 350.69 million shares).
- The most recent figure is from SANGAMO THERAPEUTICS, INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: